Abstract
Women with epithelial ovarian cancer (EOC) usually present with advanced disease and overall only just over half survive 5 years. Even following a complete response to front-line treatment two-thirds will recur, with a resultant dismal prognosis. We review and discuss the role of surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in EOC and present the results of the ovary consensus panel (OCP) convened for the 5th International Workshop on Peritoneal Surface Malignancy.
Original language | English (US) |
---|---|
Pages (from-to) | 283-290 |
Number of pages | 8 |
Journal | Journal of Surgical Oncology |
Volume | 98 |
Issue number | 4 |
DOIs | |
State | Published - Sep 15 2008 |
Externally published | Yes |
Keywords
- Cytoreductive surgery
- Epithelial ovarian cancer
- Hyperthermia
- Hyperthermic intraperitoneal chemotherapy (HIPEC)
- Intraperitoneal chemotherapy
- Loco-regional therapy
ASJC Scopus subject areas
- Surgery
- Oncology